(Q47619959)

http://europepmc.org/abstract/MED/24095194

4 February 2018

title

Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases (English)

1 reference

http://europepmc.org/abstract/MED/24095194

4 February 2018

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kevin Kemp

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Alastair Wilkins

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Neil J Scolding

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

1 October 2013

1 reference

http://europepmc.org/abstract/MED/24095194

4 February 2018

published in

The Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

9899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

1204-1213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Replacing cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Electron microscopic features of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Remyelination in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Extensive cortical remyelination in patients with chronic multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Remyelination can be extensive in multiple sclerosis despite a long disease course

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Why does remyelination fail in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Neurogenesis in the chronic lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Disease-responsive neural precursor cells are present in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Overcoming remyelination failure in multiple sclerosis and other myelin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

The lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

The relationship between relapse, impairment and disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Tremor in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Axon loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Remyelination protects axons from demyelination-associated axon degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Primary progressive multiple sclerosis: progress and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Functional heterogeneity of mesenchymal stem cells: implications for cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Mesenchymal stem cells: a new strategy for immunosuppression?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Application of hematopoietic cells to therapeutic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Adult stem cells for tissue repair - a new therapeutic concept?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Adult stem cells--reprogramming neurological repair?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Development of mesenchymal stem cells partially originate from the neural crest.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Bone marrow transdifferentiation in brain after transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Remyelination of the spinal cord following intravenous delivery of bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Inflammation, demyelination, and degeneration - recent insights from MS pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Induction and survival of binucleated Purkinje neurons by selective damage and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Cellular fusion for gene delivery to SCA1 affected Purkinje neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Mitochondria to the rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Contribution of relapses to disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

High passage number of stem cells adversely affects stem cell activation and myocardial protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Defining the risks of mesenchymal stromal cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Oligodendrocytes and stem cell transplantation: their potential in the treatment of leukoencephalopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Adipose stromal/stem cells: basic and translational advances: the IFATS collection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Multipotent adult progenitor cell isolation and proliferation in cytokine and serum-free medium conditioned by rat B104 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Can hematopoietic stem cells be an alternative source for skin regeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Stem cell therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

A randomized trial of mesenchymal stem cells in multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961810-3

7 January 2021

10.1016/S0140-6736(13)61810-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24095194%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference